FDMT Stock Ownership Activity
4D MOLECULAR THERAPEUTICS IN 13F holders
No value investing guru has made any change to the 4D MOLECULAR THERAPEUTICS IN (FDMT) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying FDMT now?
According to the latest SEC filing(s) 4D MOLECULAR THERAPEUTICS IN (FDMT) has not been purchased by any super investor.
To see more about who is investing in 4D MOLECULAR THERAPEUTICS IN (FDMT), please go to the FDMT ownership page.
2023 Q2
(1 result)
Current price: $23.25
28.67%
Reported price*: $18.07
2020 Q4
(1 result)
Current price: $23.25
43.91%
Reported price*: $41.45
2 of 2
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.